Related Experiment Video
Updated: Apr 22, 2026

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
Revisiting the Roco G-protein cycle
Susanne Terheyden1, Franz Y Ho2, Bernd K Gilsbach1
1*Department of Cell Biochemistry, University of Groningen, Nijenborgh 7, 9747 AG Groningen, The Netherlands.
Abstract:
Mutations in leucine-rich-repeat kinase 2 (LRRK2) are the most frequent cause of late-onset Parkinson's disease (PD). LRRK2 belongs to the Roco family of proteins which share a conserved Ras-like G-domain (Roc) and a C-terminal of Roc (COR) domain tandem. The nucleotide state of small G-proteins is strictly controlled by guanine-nucleotide-exchange factors (GEFs) and GTPase-activating proteins (GAPs). Because of contradictory structural and biochemical data, the regulatory mechanism of the LRRK2 Roc G-domain and the RocCOR tandem is still under debate. In the present study, we solved the first nucleotide-bound Roc structure and used LRRK2 and bacterial Roco proteins to characterize the RocCOR function in more detail. Nucleotide binding induces a drastic structural change in the Roc/COR domain interface, a region strongly implicated in patients with an LRRK2 mutation. Our data confirm previous assumptions that the C-terminal subdomain of COR functions as a dimerization device. We show that the dimer formation is independent of nucleotide. The affinity for GDP/GTP is in the micromolar range, the result of which is high dissociation rates in the s-1 range. Thus Roco proteins are unlikely to need GEFs to achieve activation. Monomeric LRRK2 and Roco G-domains have a similar low GTPase activity to small G-proteins. We show that GTPase activity in bacterial Roco is stimulated by the nucleotide-dependent dimerization of the G-domain within the complex. We thus propose that the Roco proteins do not require GAPs to stimulate GTP hydrolysis but stimulate each other by one monomer completing the catalytic machinery of the other.
Insights
Mutations in leucine-rich-repeat kinase 2 (LRRK2) cause Parkinson's disease. This study reveals how LRRK2 protein dimerization regulates its activity, suggesting it doesn't need external factors for activation or GTPase activity stimulation.
Area of Science:
- Biochemistry
- Molecular Biology
- Neuroscience
Background:
- Mutations in leucine-rich-repeat kinase 2 (LRRK2) are a primary genetic cause of late-onset Parkinson's disease (PD).
- LRRK2, a member of the Roco protein family, possesses a Roc G-domain and a COR domain, crucial for its function.
- The precise regulatory mechanism of the LRRK2 Roc-COR tandem and its nucleotide-bound state has remained unclear due to conflicting data.
Purpose of the Study:
- To elucidate the regulatory mechanism of the LRRK2 Roc-COR tandem.
- To characterize the function of the Roc-COR tandem in nucleotide binding and dimerization.
- To investigate the GTPase activity regulation in LRRK2 and related Roco proteins.
Main Methods:
- Determined the first crystal structure of a nucleotide-bound Roc domain.
- Utilized LRRK2 and bacterial Roco proteins for biochemical characterization.
- Analyzed nucleotide binding affinity and dissociation rates.
- Assessed GTPase activity of monomeric and dimeric forms.
Main Results:
- Nucleotide binding induces significant structural changes at the Roc/COR domain interface, a key mutation site in PD.
- The C-terminal subdomain of COR acts as a dimerization module, independent of nucleotide binding.
- LRRK2 and Roco proteins exhibit low affinity for GDP/GTP with rapid dissociation, suggesting GEF-independent activation.
- GTPase activity is stimulated by nucleotide-dependent dimerization, where monomers mutually enhance catalytic function, obviating the need for GAPs.
Conclusions:
- LRRK2 dimerization is a critical regulatory mechanism for its GTPase activity.
- Roco proteins likely activate themselves through dimerization, rather than relying on external GEFs or GAPs.
- These findings offer new insights into LRRK2 function and potential therapeutic strategies for Parkinson's disease.
Related Concept Videos
Activation and Inactivation of G Proteins
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
G-protein Coupled Receptors
G-protein Coupled Receptors
GTPases and their Regulation
Large G-proteins,...
GTPases and their Regulation

